Nasus Pharma Ltd
Develops powder-based intranasal drugs for rapid delivery in acute medical emergencies.
NSRX | NYSE
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 29 HARAKEVET ST, 6618003 TEL AVIV - YAFO
- Website:
- https://www.nasuspharma.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Nasus Pharma Ltd. is a clinical-stage pharmaceutical company specializing in the development of powder-based intranasal (PBI) products for acute medical conditions and emergency situations. Leveraging its proprietary microsphere technology, the company aims to provide rapid, non-invasive drug delivery to the bloodstream and brain, bypassing the blood-brain barrier. This technology is designed for superior absorption compared to traditional liquid-based solutions. Nasus Pharma's product portfolio targets public health threats and emergency medical needs, including treatments for severe allergic reactions and opioid overdose.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Nasus Pharma Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nasus Pharma Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nasus Pharma Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
